CJC1295+Ipamorelin W/DAC
Peptide combination studied in growth hormone secretion research.
Research Areas
Scientific Background
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a growth hormone secretagogue. Scientific literature has examined their mechanisms in stimulating growth hormone release from the pituitary gland.
Areas of Investigation
Laboratory Information
Technical specifications for research settings
This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.
Store at -20°C. Reconstituted solutions should be stored at 2-8°C.
Lyophilized powder blend
>97% by HPLC
Soluble in bacteriostatic water for research preparation
For in vitro and qualified research applications only.
Published Literature
Published research has explored the pharmacokinetics and mechanisms of these peptides in laboratory settings.
Regulatory Classification
These peptides are investigational compounds. Not available for compounding under current FDA regulations. For qualified research purposes only.
Important Research Notice
This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.